DOST, UP-PGH to conduct convalescent plasma transfusion as possible cure for COVID-19

The Department of Science and Technology – Philippine Council for Health Research and Development (DOST-PCHRD), together with the University of the Philippines – Philippine General Hospital (UP-PGH), will be conducting a project on convalescent plasma transfusion as possible therapy to prevent disease progression among hospitalized COVID-19 patients.

The project called “Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients with COVID-19? will provide adjunctive therapy which is a treatment used to support the main or primary treatment of diseases.

The DOST-PCHRD said that since definite therapy for COVID-19 is still lacking, the project aims to evaluate the efficacy and safety of convalescent plasma transfusion as adjunctive therapy to prevent disease progression among hospitalized COVID-19 patients. Convalescent plasma is taken from the blood of patients who recovered from the disease and contains neutralizing antibodies against it.

According to Dr. Michael Ryan, Executive Director of the Health Emergencies Program of the World Health Organization (WHO), the use of convalescent plasma transfusion is a valid approach in treating infectious diseases as demonstrated in previous outbreaks such as the H1N1 influenza virus pandemic, 2003 SARS-CoV-1 epidemic, and the 2012 MERS-CoV epidemic. In a press conference in Geneva last February, he explained that through the transfusion, “you’re giving (the patients) a boost of antibodies to hopefully get them through the very difficult phase.”

“For the past months, we have been mobilizing our resources and maximizing our capacities to help combat COVID-19. Through this project, we are hoping to provide supportive treatment to COVID-19 patients to avoid worst-case scenarios,” DOST- PCHRD Executive Director Jaime C. Montoya said.

“If the project proves to be successful, we can also contribute to developing a treatment that will help reduce the mortality rate of COVID-19,” he added.

Aside from potentially developing locally-produced convalescent plasma which may be used as part of the COVID-19 treatment regime, the project also aims to strengthen the capacities of healthcare professionals in its clinical use, not only for COVID-19, but also for other emerging infections in the future.

The team has started the call for blood donations from COVID-19 survivors in April. The project will run for 12 months.

Source: https://news.mb.com.ph/2020/06/24/dost-up-pgh-to-conduct-convalescent-plasma-transfusion-as-possible-cure-for-covid-19/?fbclid=IwAR32LC7F4-A10K8NcYt097InpMlcRSB4ik67-XfxtwB8blTSCu_85_Rk_k0

Other News from NCR

RICE FARMERS' CHILDREN TAKE ON CITY JOBS
Posted: Tuesday, July 28, 2020
Farmers believed their children will not have a future if they become rice farmers. Most Qfarmers want their children to obtain college education so they can work on non-farming jobs in urban areas or...   read full story

CHALLENGES DURING THE QUARANTINE PERIOD
Posted: Tuesday, July 28, 2020
Contrary to popular assumption that working and studying from home might bring relief, an online survey during the pandemic shows otherwise. In an online survey of 288 Filipinos conducted between Apr...   read full story

DOST-STII LAUNCHES STARBOOKS WEBINAR SERIES FOR STEM TEACHERS
Posted: Tuesday, July 28, 2020
As a result of community quarantine guidelines that continue to restrict face-to-face interactions and mass gatherings, the education sector has adopted major changes in its overall system of educatio...   read full story

DOST PATULOY NA TUMUTUGON SA HAMON NG SAKUNA
Posted: Tuesday, July 28, 2020
Sa taon-taon na binibisita ng may humigi’t kumulang sa 20 bagyo ang Pilipinas ay masasabi na natin na eksperto na ang ating mga siyentipiko at mananaliksik gayun din ang ating mga weather forecaster s...   read full story